Top compounds associated with response to NSMCE2


Feature Type Standardized
Nominal ANOVA
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.071 0.05
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.092 0.05
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.067 0.05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.05
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.071 0.05
mRNA EX-527 GDSC1000 pan-cancer AAC -0.066 0.05
mRNA Irinotecan gCSI pan-cancer AAC -0.1 0.06
mRNA embelin GDSC1000 pan-cancer AAC -0.066 0.06
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.06
mRNA regorafenib CTRPv2 pan-cancer AAC 0.07 0.06
Download CSV